Skip to main content
OpenTrials
Completed

NCT Number: NCT05124782

Virtual Management of Rheumatoid Arthritis

The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rheumatoid Arthritis Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Rheumatology Department, Cochin Hospital

Paris, IDF, 75014, France

About this study

This study will be organized in two consecutive steps:

  • A first descriptive step that will consist of a retrospective analysis of virtual consultation records of patients with RA during the pandemic and lockdown period in order to analyze on which criteria the patients were assessed and followed during this period.
  • The second step will consist in evaluating the interest of the systematic use in virtual consultation of a patient reported outcome (PRO), the RAID (Rheumatoid Arthritis Impact of Disease) questionnaire; and analyze how its results influence the rheumatologist decision-making.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria
  • Follow-up in the rheumatology department of Cochin Hospital
  • Affiliated with a social security scheme
  • Non-opposition to participating in the study
  • Patients with a valid email address (registration to the virtual consultation system)

Exclusion criteria

  • Opposition to participate to this research
  • Inability to understand or speak French
  • Patient under tutor or curator ship
  • patients under medical state help

Treatment and study plan

Rheumatoid Arthritis Impact of Disease questionnaire

Other

Rheumatoid Arthritis Impact of Disease questionnaire

Primary outcomes

  1. Rate of face to face consultation, hospitalization and therapeutic modifications

    Time frame: Inclusion

    The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

Evaluation of Rheumatoid Arthritis at the Time of Telemedicine

Acronym: ePRAT

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Nov 18, 2021
Registry last updated
Sep 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.